Danimer Scientific (DNMR) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

DNMR Stock Forecast

Danimer Scientific stock forecast is as follows: an average price target of $0.90 (represents a -89.78% downside from DNMR’s last price of $8.81) and a rating consensus of 'Hold', based on 3 wall street analysts offering a 1-year stock forecast.

DNMR Price Target

The average price target for Danimer Scientific (DNMR) is $0.90 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $1.00 to $0.80. This represents a potential -89.78% downside from DNMR's last price of $8.81.

DNMR Analyst Ratings

Hold

According to 3 Wall Street analysts, Danimer Scientific's rating consensus is 'Hold'. The analyst rating breakdown for DNMR stock is 0 'Strong Buy' (0.00%), 0 'Buy' (0.00%), 3 'Hold' (100.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Danimer Scientific Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Aug 21, 2024	Charles Neivert	Piper Sandler	$1.00	$0.41	140.96%	-88.65%
May 22, 2024	Laurence Alexander	Jefferies	$0.80	$0.81	-1.06%	-90.92%
Apr 08, 2024	Charles Neivert	Piper Sandler	$1.25	$1.05	19.05%	-85.81%

Row per page

Go to

The latest Danimer Scientific stock forecast, released on Aug 21, 2024 by Charles Neivert from Piper Sandler, set a price target of $1.00, which represents a 140.96% increase from the stock price at the time of the forecast ($0.41), and a -88.65% decrease from DNMR last price ($8.81).

Danimer Scientific Price Target by Period

	1M	3M	12M
# Anlaysts	-	1	3
Avg Price Target	-	$1.00	$1.02
Last Closing Price	$8.81	$8.81	$8.81
Upside/Downside	-100.00%	-88.65%	-88.42%

In the current month, the average price target of Danimer Scientific stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Danimer Scientific's last price of $8.81. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Aug 21, 2024	Piper Sandler	Neutral	Neutral	Hold
Aug 12, 2024	Cowen & Co.	Buy	Hold	Downgrade
May 22, 2024	Jefferies	-	Hold	Downgrade
May 20, 2024	Piper Sandler	Neutral	Neutral	Hold
Apr 08, 2024	Piper Sandler	-	Neutral	Downgrade
Apr 04, 2024	Cowen & Co.	Buy	Buy	Hold

Row per page

Go to

Danimer Scientific's last stock rating was published by Piper Sandler on Aug 21, 2024. The company gave DNMR a "Neutral" rating, the same as its previous rate.

Danimer Scientific Financial Forecast

Danimer Scientific Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	$10.95M	$10.95M	$12.87M	$11.93M	$15.32M	$10.45M	$12.70M	$14.74M	$17.73M	$13.37M	$14.47M	$13.18M
Avg Forecast	$39.86M	$35.79M	$31.72M	$27.64M	$27.75M	$24.42M	$20.09M	$14.91M	$12.76M	$8.58M	$8.98M	$10.73M	$11.57M	$14.74M	$13.90M	$14.39M	$16.43M	$12.47M	$15.36M	$21.40M	$17.69M	$14.56M	$11.80M	$12.00M
High Forecast	$39.86M	$35.79M	$31.72M	$27.64M	$27.75M	$24.42M	$20.09M	$14.91M	$12.76M	$8.60M	$8.98M	$10.73M	$11.57M	$14.74M	$13.90M	$14.39M	$16.43M	$12.47M	$15.36M	$21.40M	$17.69M	$14.56M	$11.80M	$12.00M
Low Forecast	$39.86M	$35.79M	$31.72M	$27.64M	$27.75M	$24.42M	$20.09M	$14.91M	$12.76M	$8.55M	$8.98M	$10.73M	$11.57M	$14.74M	$13.90M	$14.39M	$16.43M	$12.47M	$15.36M	$21.40M	$17.69M	$14.56M	$11.80M	$12.00M
# Analysts	1	1	1	1	1	1	1	1	1	2	1	1	2	1	1	1	1	1	1	1	1	1	1	1
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.95%	0.74%	0.93%	0.83%	0.93%	0.84%	0.83%	0.69%	1.00%	0.92%	1.23%	1.10%

Danimer Scientific's average Quarter revenue forecast for Mar 24 based on 1 analysts is $10.73M, with a low forecast of $10.73M, and a high forecast of $10.73M. DNMR's average Quarter revenue forecast represents a -1.97% decrease compared to the company's last Quarter revenue of $10.95M (Dec 23).

Danimer Scientific EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
# Analysts	1	1	1	1	1	1	1	1	1	2	1	1	2	1	1	1	1	1	1	1	1	1	1	1
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	$-31.03M	$-31.24M	$-24.97M	$-23.39M	$-30.47M	$31.97M	$-29.90M	$-31.50M	$-52.90M	$-31.74M	$-18.84M	$-9.09M
Avg Forecast	$-27.35M	$-24.56M	$-21.76M	$-18.97M	$-19.04M	$-16.76M	$-13.79M	$-10.23M	$-8.76M	$-5.89M	$-6.16M	$-31.36M	$-7.94M	$-10.12M	$-9.54M	$-28.51M	$-7.38M	$-8.11M	$-9.99M	$-25.92M	$-11.51M	$-9.47M	$-7.68M	$-48.54M
High Forecast	$-27.35M	$-24.56M	$-21.76M	$-18.97M	$-19.04M	$-16.76M	$-13.79M	$-10.23M	$-8.76M	$-5.87M	$-6.16M	$-25.09M	$-7.94M	$-10.12M	$-9.54M	$-22.81M	$-5.90M	$-8.11M	$-9.99M	$-20.73M	$-11.51M	$-9.47M	$-7.68M	$-38.83M
Low Forecast	$-27.35M	$-24.56M	$-21.76M	$-18.97M	$-19.04M	$-16.76M	$-13.79M	$-10.23M	$-8.76M	$-5.90M	$-6.16M	$-37.63M	$-7.94M	$-10.12M	$-9.54M	$-34.21M	$-8.85M	$-8.11M	$-9.99M	$-31.10M	$-11.51M	$-9.47M	$-7.68M	$-58.24M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	3.91%	3.09%	2.62%	0.82%	4.13%	-3.94%	2.99%	1.22%	4.60%	3.35%	2.45%	0.19%

1 analysts predict DNMR's average Quarter EBITDA for Dec 22 to be $-7.38M, with a high of $-5.90M and a low of $-8.85M. This is -123.08% lower than Danimer Scientific's previous annual EBITDA (Sep 22) of $31.97M.

Danimer Scientific Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
# Analysts	1	1	1	1	1	1	1	1	1	2	1	1	2	1	1	1	1	1	1	1	1	1	1	1
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	$-39.43M	$-40.16M	$-39.24M	$-36.64M	$-28.05M	$-94.88M	$-30.45M	$-26.39M	$-12.45M	$7.83M	$39.25M	$-94.73M
Avg Forecast	$-295.82M	$-299.55M	$-305.60M	$-361.97M	$-446.76M	$-473.47M	$-559.03M	$-641.64M	$-778.45M	$-929.70M	$-1.07B	$-35.23M	$-1.56B	$-1.20B	$-1.27B	$-32.03M	$-11.87M	$-24.17M	$-27.56M	$-29.12M	$-17.47M	$-8.93M	$-8.15M	$-49.77M
High Forecast	$-295.82M	$-299.55M	$-305.60M	$-361.97M	$-446.76M	$-473.47M	$-559.03M	$-641.64M	$-778.45M	$-883.22M	$-1.07B	$-28.18M	$-1.48B	$-1.20B	$-1.27B	$-25.62M	$-9.49M	$-24.17M	$-27.56M	$-23.29M	$-17.47M	$-8.93M	$-8.15M	$-39.81M
Low Forecast	$-295.82M	$-299.55M	$-305.60M	$-361.97M	$-446.76M	$-473.47M	$-559.03M	$-641.64M	$-778.45M	$-976.19M	$-1.07B	$-42.28M	$-1.60B	$-1.20B	$-1.27B	$-38.43M	$-14.24M	$-24.17M	$-27.56M	$-34.94M	$-17.47M	$-8.93M	$-8.15M	$-59.72M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.03%	0.03%	0.03%	1.14%	2.36%	3.93%	1.10%	0.91%	0.71%	-0.88%	-4.81%	1.90%

Danimer Scientific's average Quarter net income forecast for Dec 21 is $-17.47M, with a range of $-17.47M to $-17.47M. DNMR's average Quarter net income forecast represents a -323.26% decrease compared to the company's last Quarter net income of $7.83M (Sep 21).

Danimer Scientific SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
# Analysts	1	1	1	1	1	1	1	1	1	2	1	1	2	1	1	1	1	1	1	1	1	1	1	1
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	$16.89M	$16.55M	$16.84M	$18.70M	$19.55M	$19.41M	$20.98M	$22.24M	$24.21M	$26.59M	$19.08M	$10.12M
Avg Forecast	$42.07M	$37.77M	$33.47M	$29.17M	$29.29M	$25.77M	$21.20M	$15.74M	$13.47M	$9.05M	$9.48M	$11.32M	$12.21M	$15.56M	$14.67M	$15.19M	$17.34M	$13.09M	$16.13M	$22.48M	$18.58M	$15.30M	$12.39M	$5.32M
High Forecast	$42.07M	$37.77M	$33.47M	$29.17M	$29.29M	$25.77M	$21.20M	$15.74M	$13.47M	$9.08M	$9.48M	$11.32M	$12.21M	$15.56M	$14.67M	$15.19M	$17.34M	$13.09M	$16.13M	$22.48M	$18.58M	$15.30M	$12.39M	$6.38M
Low Forecast	$42.07M	$37.77M	$33.47M	$29.17M	$29.29M	$25.77M	$21.20M	$15.74M	$13.47M	$9.03M	$9.48M	$11.32M	$12.21M	$15.56M	$14.67M	$15.19M	$17.34M	$13.09M	$16.13M	$22.48M	$18.58M	$15.30M	$12.39M	$4.25M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.38%	1.06%	1.15%	1.23%	1.13%	1.48%	1.30%	0.99%	1.30%	1.74%	1.54%	1.90%

Danimer Scientific's average Quarter SG&A projection for Mar 24 is $11.32M, based on 1 Wall Street analysts, with a range of $11.32M to $11.32M. The forecast indicates a -32.94% fall compared to DNMR last annual SG&A of $16.89M (Dec 23).

Danimer Scientific EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
# Analysts	1	1	1	1	1	1	1	1	1	2	1	1	2	1	1	1	1	1	1	1	1	1	1	1
EPS	-	-	-	-	-	-	-	-	-	-	-	-	$-0.39	-	$-0.38	$-0.36	$-0.28	$-0.94	$-0.30	$-0.26	$-0.12	$0.08	$1.12	$-2.10
Avg Forecast	$-2.54	$-2.57	$-2.62	$-3.11	$-3.84	$-4.07	$-4.80	$-5.51	$-6.68	$-7.98	$-9.17	$-11.15	$-13.44	$-10.30	$-10.90	$-11.60	$-8.20	$-0.21	$-0.24	$-0.20	$-0.15	$-0.08	$-0.07	$-0.06
High Forecast	$-2.54	$-2.57	$-2.62	$-3.11	$-3.84	$-4.07	$-4.80	$-5.51	$-6.68	$-7.58	$-9.17	$-11.15	$-12.75	$-10.30	$-10.90	$-11.60	$-8.20	$-0.21	$-0.24	$-0.20	$-0.15	$-0.08	$-0.07	$-0.06
Low Forecast	$-2.54	$-2.57	$-2.62	$-3.11	$-3.84	$-4.07	$-4.80	$-5.51	$-6.68	$-8.38	$-9.17	$-11.15	$-13.78	$-10.30	$-10.90	$-11.60	$-8.20	$-0.21	$-0.24	$-0.20	$-0.15	$-0.08	$-0.07	$-0.06
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.03%	-	0.03%	0.03%	0.03%	4.53%	1.27%	1.27%	0.80%	-1.04%	-16.00%	35.00%

According to 1 Wall Street analysts, Danimer Scientific's projected average Quarter EPS for Dec 21 is $-0.15, with a low estimate of $-0.15 and a high estimate of $-0.15. This represents a -287.50% decrease compared to DNMR previous annual EPS of $0.08 (Sep 21).

Danimer Scientific Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
ALTO	Alto Ingredients	$1.38	$3.50	153.62%	Buy
OEC	Orion Engineered Carbons	$17.29	$32.00	85.08%	Buy
LTHM	Livent	$16.51	$27.33	65.54%	Buy
OLN	Olin	$41.82	$61.00	45.86%	Buy
WLK	Westlake	$126.69	$159.67	26.03%	Hold
LYB	LyondellBasell Industries	$82.56	$101.65	23.12%	Hold
IFF	International Flavors & Fragrances	$89.37	$109.46	22.48%	Buy
SQM	Sociedad Química y Minera de Chile	$37.90	$45.75	20.71%	Buy
ECVT	Ecovyst	$8.11	$9.67	19.24%	Buy
KWR	Quaker Chemical	$168.58	$192.50	14.19%	Buy
DD	DuPont de Nemours	$83.08	$93.29	12.29%	Buy
MTX	Minerals	$81.72	$90.00	10.13%	Buy
EMN	Eastman Chemical Company	$100.75	$109.61	8.79%	Buy
APD	Air Products and Chemicals	$315.88	$315.87	-0.00%	Buy
CBT	Cabot	$109.18	$108.67	-0.47%	Hold
KRO	Kronos Worldwide	$11.35	$9.50	-16.30%	Sell
DNMR	Danimer Scientific	$8.81	$0.90	-89.78%	Hold

DNMR Forecast FAQ

Is Danimer Scientific a good buy?

No, according to 3 Wall Street analysts, Danimer Scientific (DNMR) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 0 'Buy' recommendations, accounting for 0% of DNMR's total ratings.

What is DNMR's price target?

Danimer Scientific (DNMR) average price target is $0.9 with a range of $0.8 to $1, implying a -89.78% from its last price of $8.81. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Danimer Scientific stock go up soon?

According to Wall Street analysts' prediction for DNMR stock, the company can go down by -89.78% (from the last price of $8.81 to the average price target of $0.9), down by -88.65% based on the highest stock price target, and down by -90.92% based on the lowest stock price target.

Can Danimer Scientific stock reach $13?

DNMR's average twelve months analyst stock price target of $0.9 does not support the claim that Danimer Scientific can reach $13 in the near future.

What are Danimer Scientific's analysts' financial forecasts?

Danimer Scientific's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $87.18M (high $87.18M, low $87.18M), average EBITDA is $-59.818M (high $-59.818M, low $-59.818M), average net income is $-2.121B (high $-2.121B, low $-2.121B), average SG&A $92M (high $92M, low $92M), and average EPS is $-18.211 (high $-18.211, low $-18.211). DNMR's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $135.01M (high $135.01M, low $135.01M), average EBITDA is $-92.637M (high $-92.637M, low $-92.637M), average net income is $-1.263B (high $-1.263B, low $-1.263B), average SG&A $142.48M (high $142.48M, low $142.48M), and average EPS is $-10.844 (high $-10.844, low $-10.844).

Did the DNMR's actual financial results beat the analysts' financial forecasts?

Based on Danimer Scientific's last annual report (Dec 2023), the company's revenue was $46.68M, which missed the average analysts forecast of $54.6M by -14.51%. Apple's EBITDA was $-126M, beating the average prediction of $-56.098M by 123.93%. The company's net income was $-155M, missing the average estimation of $-4.066B by -96.18%. Apple's SG&A was $68.98M, beating the average forecast of $57.63M by 19.71%. Lastly, the company's EPS was $-1.52, missing the average prediction of $-46.235 by -96.71%. In terms of the last quarterly report (Dec 2023), Danimer Scientific's revenue was $10.94M, missing the average analysts' forecast of $11.57M by -5.39%. The company's EBITDA was $-31.032M, beating the average prediction of $-7.938M by 290.93%. Danimer Scientific's net income was $-39.434M, missing the average estimation of $-1.565B by -97.48%. The company's SG&A was $16.88M, beating the average forecast of $12.21M by 38.30%. Lastly, the company's EPS was $-0.39, missing the average prediction of $-13.435 by -97.10%